Breaking Down Two Broken Down Biotechs
Kir Kahlon of Scorpion Capital revisits two of his most recent targets, Berkeley Lights ($BLI) and Ginkgo Bioworks Holdings ($DNA).
Kir Kahlon of Scorpion Capital revisits two of his most recent targets, Berkeley Lights ($BLI) and Ginkgo Bioworks Holdings ($DNA).
In this new format where we look to re-examine short theses after the market and company management have had time to process and respond, Carson Block of Muddy Waters Capital does just that for his two most recent targets, Danimer Scientific ($DNMR) and Ke Holdings ($BEKE)
2021 started out with many saying it would be the end of short selling but ended up as one of the most fruitful and exciting markets for long and short investors alike.
Recent Comments